Craneware (LON:CRW)‘s stock had its “buy” rating reiterated by stock analysts at Peel Hunt in a research report issued to clients and investors on Tuesday. They presently have a GBX 2,100 ($29.01) target price on the stock. Peel Hunt’s price target would suggest a potential upside of 22.45% from the stock’s previous close.
Craneware (CRW) opened at GBX 1,715 ($23.69) on Tuesday. The stock has a market cap of $386.55 and a P/E ratio of 4,900.00. Craneware has a 12-month low of GBX 1,165 ($16.10) and a 12-month high of GBX 1,905 ($26.32).
COPYRIGHT VIOLATION NOTICE: “Craneware (CRW) Rating Reiterated by Peel Hunt” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright & trademark law. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/13/craneware-crw-rating-reiterated-by-peel-hunt.html.
Craneware Company Profile
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.
Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.